These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1934467)

  • 1. Importance of creatinine analyses of urine when screening for abused drugs.
    Lafolie P; Beck O; Blennow G; Boréus L; Borg S; Elwin CE; Karlsson L; Odelius G; Hjemdahl P
    Clin Chem; 1991 Nov; 37(11):1927-31. PubMed ID: 1934467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatinine excretion in consecutive urine samples after controlled ingestion of water.
    Franz S; Skopp G; Boettcher M; Musshoff F
    Drug Test Anal; 2019 Mar; 11(3):435-440. PubMed ID: 30276981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders.
    Duflot T; Vasse M; Guillerme J; Schrapp A; Mory C; Imbert L; Djerada Z; Protais Y; Guillin O; Goetz H; Lamoureux F
    Drug Test Anal; 2019 Sep; 11(9):1453-1459. PubMed ID: 31261442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cannabis and urine samples].
    Westin AA
    Tidsskr Nor Laegeforen; 2011 Mar; 131(6):577-80. PubMed ID: 21423309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workplace drug testing on urine samples: evidence for improving efficacy of a first-level screening programme.
    Crespi V; Maio RC; Veronesi G; Gianfagna F; Taborelli S; Ferrario MM
    Med Lav; 2015 Sep; 106(5):374-85. PubMed ID: 26384263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary excretion of cannabis metabolites].
    Kielland KB
    Tidsskr Nor Laegeforen; 1992 May; 112(12):1585-6. PubMed ID: 1615510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of creatine ingestion on urinary creatinine concentration: Does supplementation mask a heavy dilution?
    Franz S; Skopp G; Musshoff F
    Drug Test Anal; 2022 Jan; 14(1):162-168. PubMed ID: 34559477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papain: a novel urine adulterant.
    Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
    J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
    Huestis MA; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):445-54. PubMed ID: 9788519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatinine normalization of workplace urine drug tests: does it make a difference?
    Price JW
    J Addict Med; 2013; 7(2):129-32. PubMed ID: 23370934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing false-negative tests in urinary drugs-of-abuse screening.
    Luceri F; Godi F; Messeri G
    J Anal Toxicol; 1997; 21(3):244-5. PubMed ID: 9171214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.